Full-Time

Director Global Supply Planner

Confirmed live in the last 24 hours

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

No salary listed

Senior, Expert

Ireland

Category
Inventory Management
Production Planning & Scheduling
Supply Chain Management
Operations & Logistics
Required Skills
Supply Chain Management
Inventory Management
Risk Management
Requirements
  • Bachelor’s degree in Supply Chain Management, Pharmaceutical Sciences, Business Administration, or a related field (MBA or relevant advanced degree preferred)
  • 10+ years of experience in pharmaceutical supply chain management, with at least 5 years in a leadership role overseeing global or regional supply planning teams
  • Proven track record in pharmaceutical supply chain strategy, Sales & Operations Planning (S&OP), demand and supply forecasting, and risk management
  • Strong understanding of pharmaceutical production, inventory management, regulatory requirements (GxP, FDA, EMA), and distribution processes
  • Expertise in implementing and optimizing supply chain technologies and planning systems (e.g., ERP, forecasting software)
  • Exceptional leadership and team management skills, with the ability to drive change and inspire high performance in a cross-functional environment
  • Strong communication, negotiation, and interpersonal skills with the ability to collaborate effectively across diverse teams and stakeholders
  • Advanced problem-solving, analytical, and decision-making skills, with a data-driven approach to operational excellence
  • Experience in the pharmaceutical or life sciences industry with global supply chain exposure and knowledge of industry regulations
Responsibilities
  • Lead the global supply planning strategy, ensuring alignment with business objectives, regulatory compliance, and market-specific needs across all regions
  • Develop and execute strategies for global supply chain optimization, focusing on inventory management and end-to-end supply chain design specific to the pharmaceutical industry
  • Establish and champion best practices in supply planning, risk management, and disruption mitigation, ensuring compliance with industry regulations and safety standards
  • Lead and manage the global S&OP process, ensuring integrated demand and supply planning, and optimized inventory management across markets with adherence to pharmaceutical industry regulations
  • Coordinate cross-functional S&OP meetings, utilizing data to drive decisions on supply trade-offs and to resolve imbalances between demand, capacity, and supply
  • Address and resolve any supply disruptions, capacity constraints, or forecast inaccuracies, driving proactive solutions with internal teams and external suppliers while ensuring regulatory compliance
  • Lead process to develop global supply plans used for annual budgeting, ensuring alignment with network strategies, production capacity, inventory design, and purchasing needs while maintaining cost control and meeting needs of or global patients and customers
  • Monitor and report on critical KPIs such as service levels, regulatory compliance, on-time delivery, inventory turnover, and demand forecasting accuracy
  • Balance short-term execution with long-term strategic goals, ensuring the seamless execution of pharmaceutical supply operations across multiple markets
  • Build strong relationships with key stakeholders across the organization, including regulatory affairs, quality assurance, commercial, finance, external manufacturing, and logistics teams
  • Collaborate with senior leadership to ensure that the supply chain strategy supports corporate goals, while addressing both market dynamics and regulatory challenges
  • Work closely with regional and local teams to ensure supply chain strategies are tailored to meet the regulatory and market-specific needs of different regions
  • Champion process improvements and continuous innovation to enhance the agility, resilience, and efficiency of the global pharmaceutical supply chain
  • Stay informed on the latest trends, emerging technologies, and regulatory changes in the pharmaceutical industry, ensuring that the supply chain remains ahead of industry demands
  • Foster a culture of continuous improvement within the global supply planning function, leveraging innovative technologies and solutions to streamline operations and enhance decision-making
Desired Qualifications
  • MBA or relevant advanced degree preferred

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products include small molecule drugs that either enhance or inhibit muscle function, targeting conditions like heart failure, hypertrophic cardiomyopathy, amyotrophic lateral sclerosis, and spinal muscular atrophy. The company is engaged in extensive clinical trials to test these drugs, which include omecamtiv mecarbil and reldesemtiv, among others. Unlike many competitors, Cytokinetics has a strong emphasis on muscle-related therapies and has conducted over 50 clinical trials to ensure the efficacy and safety of its products. The goal of Cytokinetics is to bring effective treatments to market that address the unmet needs of patients suffering from debilitating muscle-related conditions.

Company Size

501-1,000

Company Stage

IPO

Headquarters

South San Francisco, California

Founded

1998

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased focus on personalized medicine aligns with Cytokinetics' tailored treatment approach.
  • AI in drug discovery could enhance Cytokinetics' R&D efficiency and reduce time to market.
  • FDA initiatives expedite approval for rare disease drugs, benefiting Cytokinetics' pipeline.

What critics are saying

  • Increased competition from Imbria Pharmaceuticals may impact Cytokinetics' market share.
  • Sanofi's rights to Aficamten in Greater China may limit Cytokinetics' market access.
  • Public offering at $51/share may dilute existing shareholder value and affect stock performance.

What makes Cytokinetics unique

  • Cytokinetics focuses on first-in-class muscle activators and next-in-class muscle inhibitors.
  • The company targets cardiovascular and neuromuscular diseases with unmet medical needs.
  • Cytokinetics has a robust pipeline including omecamtiv mecarbil and reldesemtiv.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-1%
GlobeNewswire
Apr 10th, 2025
Imbria Pharmaceuticals Raises $57.5M Series B Financing Round and Appoints Alvin Shih, MD as CEO

– Led by new investor Deep Track Capital, with participation from AN Ventures, Catalio Capital Management, Cytokinetics, Inc. and existing investors RA...

Here Novi
Mar 21st, 2025
Cytokinetics Launches EARTH-HCM for Hypertrophic Cardiomyopathy Awareness

Cytokinetics launches EARTH-HCM for hypertrophic cardiomyopathy awareness.

Investing.com
Mar 20th, 2025
Cytokinetics launches interactive HCM public health tool

Cytokinetics launches interactive HCM public health tool.

Medical Update Online
Mar 19th, 2025
Cytokinetics to present new findings on Aficamten and hypertrophic cardiomyopathy at ACC 2025

Cytokinetics to present new findings on Aficamten and hypertrophic cardiomyopathy at ACC 2025.

Stock Titan
Jan 6th, 2025
Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) - Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 9:00 AM Pacific Time in the Borgia Room of the Westin St. Francis Hotel in San Francisco, CA.